tiprankstipranks
Alto Neuroscience, Inc. (ANRO)
NYSE:ANRO
US Market

Alto Neuroscience, Inc. (ANRO) Income Statement

Compare
426 Followers

Alto Neuroscience, Inc. Income Statement

Last quarter (Q3 2024), Alto Neuroscience, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Alto Neuroscience, Inc.'s net income was $-16.78M. See Alto Neuroscience, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 210.00K
Gross Profit
$ -373.00K$ -342.00K$ 65.00K
Operating Expenses
$ 37.81M$ 28.85M$ 12.12M
Depreciation and Amortization
$ 373.00K$ 342.00K$ 145.00K
EBITDA
$ -34.56M$ -27.37M$ -9.04M
Operating Income
$ -37.81M$ -29.19M$ -12.06M
Other Income/Expenses
$ 1.50M$ 1.48M$ 2.87M
Pretax Income
$ -36.30M$ -27.71M$ -9.19M
Net Income
$ -36.30M$ -27.71M$ -9.19M
Per Share Metrics
$ ―$ ―$ ―
Basic EPS
$ -1.35$ -1.08$ -0.36
Diluted EPS
$ -1.35$ -1.08$ -0.36
Weighted Average Shares Outstanding
26.88M 25.57M 25.57M
Weighted Average Shares Outstanding (Diluted)
26.88M 25.57M 25.57M
Currency in USD

Alto Neuroscience, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis